fosamprenavir

(redirected from Lexiva)
Also found in: Medical.
Related to Lexiva: Telzir
Translations

fosamprenavir

n fosamprenavir m
References in periodicals archive ?
Resistant virus may gain the upper hand after a switch to Isentress but may remain under control with continued Kaletra therapy, or continued therapy with another PI boosted by Norvir (ritonavir), such as Aptivus (tipranavir), Invirase (saquinavir), Lexiva (fosamprenavir).
Vertex said it sold the royalty stream from Lexiva and Agenerase, which it licensed to Glaxo, to strengthen its financial position and invest in other programs, particularly its hepatitis C drug programs.
GlaxoSmithKline was also in focus as three of its drugs, Epzicom, Combivir and Lexiva were included in the approved treatment guidelines of the International Aids Society-USA for initial antiretroviral therapy.
70 Two Lexiva (700 mg each) once per (Lexiva) day, two Norvir (100 mg each) once ritonavir (Norvir) with per day, and either one Truvada (200 emtricitabine/tenofovir mg emtricitabine/300 mg tenofovir or (Truvada) or one Epzicom (600 mg abacavir/300 mg abacavir/lamivudine lamivudine) per day (Epzicom) NNRTI-BASED COMBINATION REGIMENS efavirenz (Sustiva) $42.
70 Two Lexiva (700 mg each) once per (Lexiva) day, two Norvir (100 mg each) once ritonavir (Norvir) with per day, and either one Truvada (200 emtricitabineAenofovir mg emtricitabine/300 mg tenofovir) (Truvada) or or one Epzicom (600 mg abacavir/ abacavir/lamivudine 300 mg lamivudine) per day (Epzicom) NNRTI-BASED COMBINATION REGIMENS efavirenz (Sustiva) $42.
On April 29, 2005 GlaxoSmithKline announced that a drug-interaction trial of Lexiva (fosamprenavir) with Nexium (esomeprazole, a proton-pump inhibitor, often used to reduce stomach acidity for relief of reflux, the unwanted flow of stomach acid into the esophagus), had found no reduction in the in the blood level of amprenavir.
Vertex co-promotes the new HIV protease inhibitor Lexiva with GlaxoSmithKline.
The PIs were Agen-erase or Lexiva (amprenavir or fosamprenavir).
2) [dagger] Lexiva (fosamprenavir) should penetrate CSF similarly to Agenerase (amprenavir).
Food and Drug Administration approved the protease inhibitor Lexiva (generic name fosamprenavir, also called 908).
Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.